Epigenetics in Alzheimer’s disease: from molecular mechanisms to emerging novel biomarkers
Alzheimer’s disease (AD) is an age-related progressive neurodegenerative disorder that represents the leading cause of dementia worldwide, affecting over 50 million people. This global burden is expected to rise dramatically over the coming decades because of global population aging, representing a public health concer...